Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse

Vittorio Montefusco, Alessandro Corso, Monica Galli, Ilaria Ardoino, Sara Pezzatti, Cristina Carniti, Francesca Patriarca, Filippo Gherlinzoni, Renato Zambello, Simona Sammassimo, Magda Marcatti, Andrea Nozza, Claudia Crippa, Anna Maria Cafro, Luca Baldini, Paolo Corradini

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse'. Together they form a unique fingerprint.

Medicine & Life Sciences